Erwin Loh: Primary Prevention of Cardiovascular Events With Evolocumab in High-Risk Patients With Diabetes
Erwin Loh, Director of Medical Services at Peninsula Private Hospital, Ramsay Health Care, President at Royal Australasian College of Medical Administrators, shared a post on LinkedIn about a recent article by Nicholas A. Marston et al, adding:
“Targeted cholesterol-lowering therapy can prevent first heart attack or stroke in high-risk patients with diabetes
Researchers found that the intensive cholesterol‑lowering therapy evolocumab reduced the risk of a first major cardiovascular event in high‑risk patients who did not have known atherosclerosis (the build-up of plaque inside artery walls) but did have diabetes.
Results were presented at the American College of Cardiology’s Annual Scientific Session and Expo and simultaneously published in JAMA.”
Title: Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes
Authors: Nicholas A. Marston, Erin A. Bohula, Ajay K. Bhatia, Gaetano M. De Ferrari, Lawrence A. Leiter, Jose C. Nicolau, Jeong-Gun Park, Sabina A. Murphy, Emileigh Walsh, Lyrica Liu, Subodh Verma, Naveed Sattar, Stephen J. Nicholls, Jose Lopez-Sendon, Ioanna Gouni-Berthold, Lale Tokgozoglu, Ron Blankstein, Marcoli Cyrille, Gabriel Paiva da Silva Lima, Robert P. Giugliano, Marc S. Sabatine
Read the Full Article on JAMA.

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 14, 2026, 16:26Antonio Paul: The Best Transfusion Is the One That Isn’t Needed
-
Aug 14, 2026, 16:24Thirunavukkarasu Angappan: What mRNA Manufacturing Teaches Us About Scaling Hemophilia Gene Therapy
-
Aug 14, 2026, 16:16Priyanka Raheja: Advancing Multidisciplinary Care for Women with Bleeding Disorders
-
Aug 14, 2026, 16:09Cristina Chang: Hemophilia B Gene Therapy BBM-H901 Approved in Macao
-
Aug 14, 2026, 16:03Muhammad Shaheer Bin Faheem: The Growing Mortality Divide in Thromboembolism and Hypertension
-
Aug 14, 2026, 15:53Peter Jaworski: Plasma Donation Myths and Why Plasma Matters
-
Aug 14, 2026, 15:50John Strouse: Why Older Adults with Sickle Cell Disease Should Be Included in Clinical Trials
-
Aug 14, 2026, 15:44Scott Cameron: Understanding Sex Differences in Platelet Biology
-
Aug 14, 2026, 15:35Daniel Witt: Why Patient Education Matters in Anticoagulation Care